Stay updated on Empagliflozin Effect on Tissue Sodium in Heart Failure Clinical Trial
Sign up to get notified when there's something new on the Empagliflozin Effect on Tissue Sodium in Heart Failure Clinical Trial page.

Latest updates to the Empagliflozin Effect on Tissue Sodium in Heart Failure Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedThe page revision label was updated to v3.5.4, replacing the previous v3.5.3. This reflects a minor update to the page without changes to the core study content.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedThe page revision label was updated from v3.5.2 to v3.5.3, reflecting an internal/website version change rather than a change to the clinical study record.SummaryDifference0.1%

- Check45 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed.SummaryDifference0.1%

- Check74 days agoChange DetectedRevision label updated to v3.5.0 and previous revision v3.4.3 removed. This reflects a backend update to the page's versioning rather than changes to study data.SummaryDifference0.1%

- Check81 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check96 days agoChange DetectedAdded the final published reference (Eur J Heart Fail, 2025) and removed the online-ahead-of-print citation for the study publications section.SummaryDifference0.1%

Stay in the know with updates to Empagliflozin Effect on Tissue Sodium in Heart Failure Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Empagliflozin Effect on Tissue Sodium in Heart Failure Clinical Trial page.